CLINICAL TRIALS PROFILE FOR JATENZO
✉ Email this page to a colleague
All Clinical Trials for jatenzo
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT03973840 ↗ | Assessment of Blood From Men Receiving Oral TU in Various Collection Tubes | Completed | Celerion; Syneos Health; ARUP Laboratories | Phase 1 | 2018-07-15 | To describe the rate of post-collection TU to testosterone conversion, as manifested by increases in testosterone concentration, in Plain tubes held at room temperature and sodium fluoride (NaF)-ethylenediaminetetraacetic acid (EDTA) tubes held at room temperature or on ice prior to centrifugation |
NCT03973840 ↗ | Assessment of Blood From Men Receiving Oral TU in Various Collection Tubes | Completed | Clarus Therapeutics, Inc. | Phase 1 | 2018-07-15 | To describe the rate of post-collection TU to testosterone conversion, as manifested by increases in testosterone concentration, in Plain tubes held at room temperature and sodium fluoride (NaF)-ethylenediaminetetraacetic acid (EDTA) tubes held at room temperature or on ice prior to centrifugation |
NCT04983940 ↗ | Patient Satisfaction After Switching to Oral Testosterone Undecanoate | Recruiting | Clarus Therapeutics | Phase 4 | 2021-06-18 | The purpose of this research study is to evaluate patient satisfaction with an oral testosterone agent, Jatenzo, compared to other forms of testosterone therapy. |
NCT04983940 ↗ | Patient Satisfaction After Switching to Oral Testosterone Undecanoate | Recruiting | University of Miami | Phase 4 | 2021-06-18 | The purpose of this research study is to evaluate patient satisfaction with an oral testosterone agent, Jatenzo, compared to other forms of testosterone therapy. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for jatenzo
Condition Name
Clinical Trial Locations for jatenzo
Trials by Country
Clinical Trial Progress for jatenzo
Clinical Trial Phase
Clinical Trial Sponsors for jatenzo
Sponsor Name